Home Carboxes 32701-75-0
32701-75-0,MFCD05677521
Catalog No.:AA007IW8

32701-75-0 | (3,5-Dimethyl-1h-pyrazol-4-yl)-acetic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$112.00   $78.00
- +
1g
98%
in stock  
$245.00   $171.00
- +
5g
98%
in stock  
$942.00   $660.00
- +
10g
98%
in stock  
$1,524.00   $1,067.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA007IW8
Chemical Name:
(3,5-Dimethyl-1h-pyrazol-4-yl)-acetic acid
CAS Number:
32701-75-0
Molecular Formula:
C7H10N2O2
Molecular Weight:
154.1665
MDL Number:
MFCD05677521
SMILES:
OC(=O)Cc1c(C)n[nH]c1C
Properties
Computed Properties
 
Complexity:
161  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
2  
XLogP3:
0.5  

Downstream Synthesis Route

[1]CurrentPatentAssignee:IP21POINNOVATIONSLIMITED-WO2013/83991,2013,A1Locationinpatent:Page/Pagecolumn64

[2]Rackham,MarkD.;Brannigan,JamesA.;Rangachari,Kaveri;Meister,Stephan;Wilkinson,AnthonyJ.;Holder,AnthonyA.;Leatherbarrow,RobinJ.;Tate,EdwardW.[JournalofMedicinalChemistry,2014,vol.57,#6,p.2773-2788]

[3]Lumpov,A.A.;Miroslavov,A.E.;Sidorenko,G.V.;Gorshkov,N.I.;Suglobov,D.N.[Journaloflabelledcompoundsandradiopharmaceuticals,2003,vol.46,p.S258-S258]Miroslavov,A.E.;Sidorenko,G.V.;Lumpov,A.A.;Gorshkov,N.I.;Suglobov,D.N.[Journaloflabelledcompoundsandradiopharmaceuticals,2003,vol.46,p.S250-S250]

32701-75-0   
lithiumdibromoacetate 
 
bis-(4-carboxymethyl-3,5-dimethyl-pyrazol-1-yl)-aceticacid 

[1]Miroslavov,A.E.;Sidorenko,G.V.;Lumpov,A.A.;Gorshkov,N.I.;Suglobov,D.N.[Journaloflabelledcompoundsandradiopharmaceuticals,2003,vol.46,p.S250-S250]

23357-52-0    32701-75-0   
2-(3,5-dimethyl-1H-pyrazol-4-yl)-N-1,2,3,4-tetrahydro-1-naphthalenylacetamide 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2007/141267,2007,A1Locationinpatent:Page/Pagecolumn31

[1]Lumpov,A.A.;Miroslavov,A.E.;Sidorenko,G.V.;Gorshkov,N.I.;Suglobov,D.N.[Journaloflabelledcompoundsandradiopharmaceuticals,2003,vol.46,p.S258-S258]Miroslavov,A.E.;Sidorenko,G.V.;Lumpov,A.A.;Gorshkov,N.I.;Suglobov,D.N.[Journaloflabelledcompoundsandradiopharmaceuticals,2003,vol.46,p.S250-S250]

[2]CurrentPatentAssignee:IP21POINNOVATIONSLIMITED-WO2013/83991,2013,A1

[3]Rackham,MarkD.;Brannigan,JamesA.;Rangachari,Kaveri;Meister,Stephan;Wilkinson,AnthonyJ.;Holder,AnthonyA.;Leatherbarrow,RobinJ.;Tate,EdwardW.[JournalofMedicinalChemistry,2014,vol.57,#6,p.2773-2788]

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:32701-75-0 Molecular Formula|32701-75-0 MDL|32701-75-0 SMILES|32701-75-0 (3,5-Dimethyl-1h-pyrazol-4-yl)-acetic acid